Comparison of postoperative outcomes following endoscopic third ventriculostomy or shunt in a propensity score matched pediatric cohort
Comparison of postoperative outcomes following endoscopic third ventriculostomy or shunt in a propensity score matched pediatric cohort

Comparison of postoperative outcomes following endoscopic third ventriculostomy or shunt in a propensity score matched pediatric cohort

Childs Nerv Syst. 2025 Jul 31;41(1):250. doi: 10.1007/s00381-025-06886-2.

ABSTRACT

PURPOSE: Thirty-day readmission and reoperation are widely used quality metrics. Endoscopic third ventriculostomy (ETV) is favored when feasible, but may compare unfavorably with shunt in the short-term. This study analyzes 30-day outcomes of ETV and shunt surgery in comparable populations.

METHODS: Data regarding patients undergoing ETV or initial shunt insertion were extracted from the National Surgical Quality Improvement Program – Pediatric for 2013-2020. Patients were stratified into three age groups: ≤ 6 months (N = 5,906), 6 months-2 years (N = 2,364), and ≥ 2 years (N = 4,408). Characteristics were compared before and after propensity-score matching. Outcome comparisons included CNS complications, mortality, readmission, and reinterventions.

RESULTS: There were 10,135 shunt insertions and 2,543 ETVs. After matching, patients ≤ 6 months undergoing ETV had more seizures (ETV 6.3% vs shunt 0.4%, p < 0.001), readmission (ETV 15.7% vs shunt 6.1%, p < 0.001), and reintervention (ETV 17.4% vs shunt 4.8%, p < 0.001). Among patients 6 months-2 years, ETV increased seizures (ETV 3.3% vs shunt 1.0%, p = 0.01), readmission (ETV 14.9% vs shunt 7.8%, p < 0.001), and reintervention (ETV 13.0% vs shunt 5.4%, p < 0.001). Among older patients, ETV had decreased median length of stay (ETV 3 days, IQR 1-6 days vs shunt 3 days, IQR 2-8 days, p = 0.0019) and mortality (ETV 0.4% vs shunt 1.5%, p = 0.007).

CONCLUSION: Outcomes following shunt surgery and ETV in matched patients appear to be age-dependent. Younger patients undergoing ETV encountered more short-term complications. 30-day outcomes may be misleading as a quality measure in the management of childhood hydrocephalus.

PMID:40739048 | DOI:10.1007/s00381-025-06886-2